MWA Asset Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABBV
MWA Asset Management's ABBV Position: Q2 2026 in Review
MWA Asset Management increased its AbbVie (ABBV) stake by 1.4% in Q2 2026, buying an estimated $55.1K and bringing the position to 18,170 shares worth $4.57M. The position accounts for 2.07% of the portfolio, ranked #14.
MWA Asset Management first reported a position in ABBV in Q3 2023 and has held it in 12 quarters since. 4,194 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- MWA Asset Management held 18,170 shares of AbbVie worth $4.57M as of Q2 2026.
- MWA Asset Management bought 256 AbbVie shares in Q2 2026, an estimated $55.1K.
- AbbVie made up 2.07% of MWA Asset Management's portfolio in Q2 2026, its #14 holding.
- MWA Asset Management first reported a position in AbbVie in Q3 2023 and has held it in 12 quarters since.
- 4,194 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on MWA Asset Management's 13F filing for Q2 2026, filed 31 Jul 2026.